CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Baricitinib

巴瑞替尼 杂质对照品Baricitinib Impurities

72 个杂质条目72 impurity entries

本页汇总 巴瑞替尼 的 72 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 72 impurity reference standards of Baricitinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 巴瑞替尼(Baricitinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesIdentification, Synthesis, and Characterization of Novel Baricitinib Impurities
    ACS omega · 2023 · Vaddamanu G et al.  ·  PMID 36936292  ·  DOI
  2. 杂质研究Impurity studiesForced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy
    Rapid communications in mass spectrometry : RCM · 2023 · Chaganti S et al.  ·  PMID 37580847  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of [(2) H(5) ]baricitinib via [(2) H(5) ]ethanesulfonyl chloride
    Journal of labelled compounds & radiopharmaceuticals · 2022 · Jansen-van Vuuren RD, Vohra R  ·  PMID 35277889  ·  DOI
  • 合成方法SynthesisA green and facile synthesis of an industrially important quaternary heterocyclic intermediates for baricitinib
    BMC chemistry · 2019 · Cui X et al.  ·  PMID 31696160  ·  DOI

巴瑞替尼 —— 原料药与杂质对照品Baricitinib — drug substance & impurities

共 73 个条目(含原料药本体)73 items incl. the drug substance
Baricitinib structure
原料药 APIAPI
巴瑞替尼Baricitinib
Baricitinib
CAS No.1187594-09-7
Chemical FormulaC16H17N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 1 structure
1
巴瑞替尼杂质1Baricitinib Impurity 1
Baricitinib Impurity 1
CAS No.2402776-83-2
Chemical FormulaC16H17N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 2  Hydrochloride structure
2
巴瑞替尼杂质2 盐酸盐Baricitinib Impurity 2 Hydrochloride
Baricitinib Impurity 2 Hydrochloride
CAS No.1803583-30-3
Chemical FormulaC9H7N5·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 2 structure
2
巴瑞替尼杂质2Baricitinib Impurity 2
Baricitinib Impurity 2
CAS No.952518-97-7
Chemical FormulaC9H7N5
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 3 structure
3
巴瑞替尼杂质3Baricitinib Impurity 3
Baricitinib Impurity 3
CAS No.2271228-51-2
Chemical FormulaC16H19N7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 4 structure
4
巴瑞替尼杂质4Baricitinib Impurity 4
Baricitinib Impurity 4
CAS No.1187594-16-6
Chemical FormulaC14H13N7
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 4 Hydrochloride structure
4
巴瑞替尼杂质4 盐酸盐Baricitinib Impurity 4 Hydrochloride
Baricitinib Impurity 4 Hydrochloride
CAS No.2497340-56-2
Chemical FormulaC14H13N7·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 5 structure
5
巴瑞替尼杂质5Baricitinib Impurity 5
Baricitinib Impurity 5
CAS No.2271228-52-3
Chemical FormulaC16H18N6O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 6 structure
6
巴瑞替尼杂质6Baricitinib Impurity 6
Baricitinib Impurity 6
CAS No.2402776-81-0
Chemical FormulaC13H14ClN5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 7 structure
7
巴瑞替尼杂质7Baricitinib Impurity 7
Baricitinib Impurity 7
CAS No.1187595-89-6
Chemical FormulaC17H19N7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 8 structure
8
巴瑞替尼杂质8Baricitinib Impurity 8
Baricitinib Impurity 8
CAS No.2514763-82-5
Chemical FormulaC16H17N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 10 structure
10
巴瑞替尼杂质10Baricitinib Impurity 10
Baricitinib Impurity 10
CAS No.1153949-11-1
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 11 structure
11
巴瑞替尼杂质11Baricitinib Impurity 11
Baricitinib Impurity 11
CAS No.2402776-84-3
Chemical FormulaC23H27N9O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 13 structure
13
巴瑞替尼杂质13Baricitinib Impurity 13
Baricitinib Impurity 13
CAS No.2761352-71-8
Chemical FormulaC14H17N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 14 structure
14
巴瑞替尼杂质14Baricitinib Impurity 14
Baricitinib Impurity 14
CAS No.2821844-77-1
Chemical FormulaC7H6ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 19 Hydrochloride structure
19
巴瑞替尼杂质19 盐酸盐Baricitinib Impurity 19 Hydrochloride
Baricitinib Impurity 19 Hydrochloride
CAS No.240805-24-7
Chemical FormulaC5H7NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 19 structure
19
巴瑞替尼杂质19Baricitinib Impurity 19
Baricitinib Impurity 19
CAS No.775271-06-2
Chemical FormulaC5H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 20 structure
20
巴瑞替尼杂质20Baricitinib Impurity 20
Baricitinib Impurity 20
CAS No.2964606-42-4
Chemical FormulaC15H17N7O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 21 structure
21
巴瑞替尼杂质21Baricitinib Impurity 21
Baricitinib Impurity 21
CAS No.2964606-44-6
Chemical FormulaC15H15N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 23 structure
23
巴瑞替尼杂质23Baricitinib Impurity 23
Baricitinib Impurity 23
CAS No.442847-52-1
Chemical FormulaC12H17Cl2N3OSi
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 25 structure
25
巴瑞替尼杂质25Baricitinib Impurity 25
Baricitinib Impurity 25
CAS No.1187595-88-5
Chemical FormulaC19H29N5O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 26 structure
26
巴瑞替尼杂质26Baricitinib Impurity 26
Baricitinib Impurity 26
CAS No.894807-98-8
Chemical FormulaC15H29BN2O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 27 structure
27
巴瑞替尼杂质27Baricitinib Impurity 27
Baricitinib Impurity 27
CAS No.1911644-33-1
Chemical FormulaC13H15N5O
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 28  Hydrochloride structure
28
巴瑞替尼杂质28 盐酸盐Baricitinib Impurity 28 Hydrochloride
Baricitinib Impurity 28 Hydrochloride
CAS No.1314910-43-4
Chemical FormulaC5H6N2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 28 structure
28
巴瑞替尼杂质28Baricitinib Impurity 28
Baricitinib Impurity 28
CAS No.1315059-55-2
Chemical FormulaC5H6N2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 29 structure
29
巴瑞替尼杂质29Baricitinib Impurity 29
Baricitinib Impurity 29
CAS No.1187594-13-3
Chemical FormulaC22H31N7O3SSi
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 32 structure
32
巴瑞替尼杂质32Baricitinib Impurity 32
Baricitinib Impurity 32
CAS No.1187594-12-2
Chemical FormulaC20H27N7OSi
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 34 structure
34
巴瑞替尼杂质34Baricitinib Impurity 34
Baricitinib Impurity 34
CAS No.1919837-50-5
Chemical FormulaC16H25BN4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 40 structure
40
巴瑞替尼杂质40Baricitinib Impurity 40
Baricitinib Impurity 40
CAS No.1269823-19-9
Chemical FormulaC19H21N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 43 structure
43
巴瑞替尼杂质43Baricitinib Impurity 43
Baricitinib Impurity 43
CAS No.1401222-91-0
Chemical FormulaC5H9NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 44 structure
44
巴瑞替尼杂质44Baricitinib Impurity 44
Baricitinib Impurity 44
CAS No.2910813-45-3
Chemical FormulaC22H20N10O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 45 structure
45
巴瑞替尼杂质45Baricitinib Impurity 45
Baricitinib Impurity 45
CAS No.1187594-34-8
Chemical FormulaC17H19N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 48 structure
48
巴瑞替尼杂质48Baricitinib Impurity 48
Baricitinib Impurity 48
CAS No.2402776-80-9
Chemical FormulaC17H20N6O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 51 structure
51
巴瑞替尼杂质51Baricitinib Impurity 51
Baricitinib Impurity 51
CAS No.2434-56-2
Chemical FormulaC4H6N4
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 52 structure
52
巴瑞替尼杂质52Baricitinib Impurity 52
Baricitinib Impurity 52
CAS No.1029716-44-6
Chemical FormulaC13H23BN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 53 structure
53
巴瑞替尼杂质53Baricitinib Impurity 53
Baricitinib Impurity 53
CAS No.1187595-85-2
Chemical FormulaC7H10N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 54 structure
54
巴瑞替尼杂质54Baricitinib Impurity 54
Baricitinib Impurity 54
CAS No.1638759-68-8
Chemical FormulaC6H8N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 55 structure
55
巴瑞替尼杂质55Baricitinib Impurity 55
Baricitinib Impurity 55
CAS No.2101302-47-8
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 57 Hydrochloride structure
57
巴瑞替尼杂质57 盐酸盐Baricitinib Impurity 57 Hydrochloride
Baricitinib Impurity 57 Hydrochloride
CAS No.1256346-38-9
Chemical FormulaC3H5BN2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 57 structure
57
巴瑞替尼杂质57Baricitinib Impurity 57
Baricitinib Impurity 57
CAS No.763120-58-7
Chemical FormulaC3H5BN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 58 structure
58
巴瑞替尼杂质58Baricitinib Impurity 58
Baricitinib Impurity 58
CAS No.1865785-69-8
Chemical FormulaC7H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 60 structure
60
巴瑞替尼杂质60Baricitinib Impurity 60
Baricitinib Impurity 60
CAS No.3053239-95-2
Chemical FormulaC12H15N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 63 structure
63
巴瑞替尼杂质63Baricitinib Impurity 63
Baricitinib Impurity 63
CAS No.1187595-90-9
Chemical FormulaC22H27N7O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 66 structure
66
巴瑞替尼杂质66Baricitinib Impurity 66
Baricitinib Impurity 66
CAS No.1146629-75-5
Chemical FormulaC12H14ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 67 structure
67
巴瑞替尼杂质67Baricitinib Impurity 67
Baricitinib Impurity 67
CAS No.1146629-76-6
Chemical FormulaC19H25N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 68 structure
68
巴瑞替尼杂质68Baricitinib Impurity 68
Baricitinib Impurity 68
CAS No.1146629-77-7
Chemical FormulaC15H17N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 69 structure
69
巴瑞替尼杂质69Baricitinib Impurity 69
Baricitinib Impurity 69
CAS No.941685-26-3
Chemical FormulaC12H18ClN3OSi
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 70 structure
70
巴瑞替尼杂质70Baricitinib Impurity 70
Baricitinib Impurity 70
CAS No.18621-18-6
Chemical FormulaC3H7NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 72 structure
72
巴瑞替尼杂质72Baricitinib Impurity 72
Baricitinib Impurity 72
CAS No.1340173-28-5
Chemical FormulaC5H11NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 76 structure
76
巴瑞替尼杂质76Baricitinib Impurity 76
Baricitinib Impurity 76
CAS No.2227194-01-4
Chemical FormulaC7H13BN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 76  Sodium Salt structure
76
巴瑞替尼杂质76 钠盐Baricitinib Impurity 76 Sodium Salt
Baricitinib Impurity 76 Sodium Salt
CAS No.2920037-85-8
Chemical FormulaC7H11BN2O32-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 77 structure
77
巴瑞替尼杂质77Baricitinib Impurity 77
Baricitinib Impurity 77
CAS No.2101302-57-0
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 81 structure
81
巴瑞替尼杂质81Baricitinib Impurity 81
Baricitinib Impurity 81
CAS No.2166596-69-4
Chemical FormulaC12H19N3O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 82 structure
82
巴瑞替尼杂质82Baricitinib Impurity 82
Baricitinib Impurity 82
CAS No.1236033-21-8
Chemical FormulaC11H12ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 83 structure
83
巴瑞替尼杂质83Baricitinib Impurity 83
Baricitinib Impurity 83
CAS No.2055723-13-0
Chemical FormulaC21H25N7O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 84 structure
84
巴瑞替尼杂质84Baricitinib Impurity 84
Baricitinib Impurity 84
CAS No.1153942-94-9
Chemical FormulaC21H21N7O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 86 structure
86
巴瑞替尼杂质86Baricitinib Impurity 86
Baricitinib Impurity 86
CAS No.1024120-52-2
Chemical FormulaC7H11BrN2O
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 89 structure
89
巴瑞替尼杂质89Baricitinib Impurity 89
Baricitinib Impurity 89
CAS No.18994-91-7
Chemical FormulaC7H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 93 structure
93
巴瑞替尼杂质93Baricitinib Impurity 93
Baricitinib Impurity 93
CAS No.2055723-11-8
Chemical FormulaC7H15NO5S2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 98 structure
98
巴瑞替尼杂质98Baricitinib Impurity 98
Baricitinib Impurity 98
CAS No.1099670-02-6
Chemical FormulaC8H6ClN5
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 99 structure
99
巴瑞替尼杂质99Baricitinib Impurity 99
Baricitinib Impurity 99
CAS No.2910813-43-1
Chemical FormulaC16H18N6O4S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 103 structure
103
巴瑞替尼杂质103Baricitinib Impurity 103
Baricitinib Impurity 103
CAS No.398489-26-4
Chemical FormulaC8H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 104 structure
104
巴瑞替尼杂质104Baricitinib Impurity 104
Baricitinib Impurity 104
CAS No.6645-68-7
Chemical FormulaC3HI3N2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 106 structure
106
巴瑞替尼杂质106Baricitinib Impurity 106
Baricitinib Impurity 106
CAS No.6645-70-1
Chemical FormulaC3H2I2N2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 111 structure
111
巴瑞替尼杂质111Baricitinib Impurity 111
Baricitinib Impurity 111
CAS No.1309430-77-0
Chemical FormulaC8H9N3O
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 119 structure
119
巴瑞替尼杂质119Baricitinib Impurity 119
Baricitinib Impurity 119
CAS No.1119280-66-8
Chemical FormulaC6H4ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 120 structure
120
巴瑞替尼杂质120Baricitinib Impurity 120
Baricitinib Impurity 120
CAS No.1195-66-0
Chemical FormulaC7H15BO3
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 121 structure
121
巴瑞替尼杂质121Baricitinib Impurity 121
Baricitinib Impurity 121
CAS No.14521-80-3
Chemical FormulaC3H3BrN2
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 124 structure
124
巴瑞替尼杂质124Baricitinib Impurity 124
Baricitinib Impurity 124
CAS No.2101302-36-5
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 126 structure
126
巴瑞替尼杂质126Baricitinib Impurity 126
Baricitinib Impurity 126
CAS No.2101302-27-4
Chemical FormulaC22H30ClN7O3SSi
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 127 structure
127
巴瑞替尼杂质127Baricitinib Impurity 127
Baricitinib Impurity 127
CAS No.2101302-32-1
Chemical FormulaC22H30ClN7O3SSi
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 130 structure
130
巴瑞替尼杂质130Baricitinib Impurity 130
Baricitinib Impurity 130
CAS No.2101301-53-3
Chemical FormulaC16H16ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Baricitinib Impurity 131 structure
131
巴瑞替尼杂质131Baricitinib Impurity 131
Baricitinib Impurity 131
CAS No.2101301-55-5
Chemical FormulaC16H16ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

巴瑞替尼 —— 研究文献与合成路线Baricitinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 巴瑞替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Baricitinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy
    Chaganti S, Dhiman V, Madhyanapu Golla V, et al. · Rapid communications in mass spectrometry : RCM · 2023 · 被引 7cited 7
  2. Identification, Synthesis, and Characterization of Novel Baricitinib Impurities
    Vaddamanu G, Goswami A, Reddy NRS, et al. · ACS omega · 2023 · 被引 4cited 4

合成路线文献Synthetic-route papers

  1. Identification, Synthesis, and Characterization of Novel Baricitinib Impurities
    Vaddamanu G, Goswami A, Reddy NRS, et al. · ACS omega · 2023
  2. Design, synthesis, and biological evaluation of novel ruxolitinib and baricitinib analogues for potential use against COVID-19
    Lin Q, Li J, Wang Y, et al. · Chemical biology & drug design · 2023
  3. Synthesis of [2 H5 ]baricitinib via [2 H5 ]ethanesulfonyl chloride
    Jansen-van Vuuren RD, Vohra R · Journal of labelled compounds & radiopharmaceuticals · 2022

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

巴瑞替尼 杂质谱研究要点Baricitinib — impurity profiling notes

下面这些是拿到 巴瑞替尼 的 73 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 73 impurity entries for Baricitinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances